These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20385333)

  • 41. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
    Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
    Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of acromegaly on thyroid disease.
    Mo C; Zhong L
    Endocr J; 2023 Nov; 70(11):1051-1060. PubMed ID: 37880078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot study.
    Lanzolla G; Ricci D; Nicolì F; Sabini E; Sframeli A; Brancatella A; Mantuano M; Dottore GR; Bucci I; Figus M; Nardi M; Latrofa F; Marcocci C; Marinò M
    J Endocrinol Invest; 2020 Dec; 43(12):1759-1768. PubMed ID: 32583374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IGF1 receptor and thyroid-associated ophthalmopathy.
    Mohyi M; Smith TJ
    J Mol Endocrinol; 2018 Jul; 61(1):T29-T43. PubMed ID: 29273685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotherapy for Graves' ophthalmopathy.
    Salvi M
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):409-14. PubMed ID: 25105999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.
    McCoy AN; Kim DS; Gillespie EF; Atkins SJ; Smith TJ; Douglas RS
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1294-9. PubMed ID: 24670080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
    Fernando R; Placzek E; Reese EA; Placzek AT; Schwartz S; Trierweiler A; Niziol LM; Raychaudhuri N; Atkins S; Scanlan TS; Smith TJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):776-785. PubMed ID: 27768856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Insulin-like Growth Factor-1 and Its Receptor in the Eye: A Review and Implications for IGF-1R Inhibition.
    Truong T; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):4-12. PubMed ID: 36598389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
    Smith TJ; Tsai CC; Shih MJ; Tsui S; Chen B; Han R; Naik V; King CS; Press C; Kamat S; Goldberg RA; Phipps RP; Douglas RS; Gianoukakis AG
    Thyroid; 2008 Sep; 18(9):983-8. PubMed ID: 18788919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy.
    Janssen JAMJL; Smith TJ
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.
    Fonte R; Pirali B; Caramia V; Dionisio R; Lodigiani S; Sibilla L; Rotondi M; Chiovato L
    Thyroid; 2011 Dec; 21(12):1389-92. PubMed ID: 22066480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sphingolipids in thyroid eye disease.
    Gulbins A; Görtz GE; Gulbins E; Eckstein A
    Front Endocrinol (Lausanne); 2023; 14():1170884. PubMed ID: 37082124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy.
    Smith TJ
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():129-148. PubMed ID: 30044728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.
    Chen H; Shan SJ; Mester T; Wei YH; Douglas RS
    PLoS One; 2015; 10(6):e0130322. PubMed ID: 26087256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TSHR as a therapeutic target in Graves' disease.
    Smith TJ
    Expert Opin Ther Targets; 2017 Apr; 21(4):427-432. PubMed ID: 28127991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.
    Gianoukakis AG; Smith TJ
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):446-52. PubMed ID: 18769218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.
    Neumann S; Krieger CC; Gershengorn MC
    Eur Thyroid J; 2020 Dec; 9(Suppl 1):59-65. PubMed ID: 33511086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kumar S; Coenen M; Iyer S; Bahn RS
    Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.